McDonaghJMartinLFergusonC, et al. Frailty assessment instruments in heart failure: a systematic review. Eur J Cardiovasc Nurs2018; 17: 23–35.
2.
AnkerSSteinbornWStrassburgS.Cardiac cachexia. Ann Med2004; 36: 518–529.
3.
BallJLøchenM-LCarringtonMJ, et al. Impact of body mass index on mortality and hospitalisation of patients with atrial fibrillation. Eur J Cardiovasc Nurs2018; 17: 627–636.
4.
von HaehlingSAnkerSD. Prevalence, incidence and clinical impact of cachexia: facts and numbers – update 2014. J Cachexia Sarcopenia Muscle2014; 5: 261–263.
5.
BrännströmMBomanK.A new model for integrated heart failure and palliative advanced homecare − rationale and design of a prospective randomized study. Eur J Cardiovasc Nurs2013; 12: 269–275.
6.
SpringerJVon HaehlingSAnkerSD.The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab2006; 2: 416–417.
7.
EvansWJMorleyJEArgilésJ, et al. Cachexia: a new definition. Clin Nutr2008; 27: 793–799.
8.
EbnerNElsnerSSpringerJ, et al. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure. Curr Opin Support Palliat Care2014; 8: 15–24.
9.
PurezaVFloreaVG.Mechanisms for cachexia in heart failure. Curr Heart Fail Rep2013; 10: 307–314.
10.
LoncarGSpringerJAnkerM, et al. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle2016; 7: 246–260.
11.
TomlinsonDJErskineRMMorseCI, et al. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology2016; 17: 467–483.
12.
FearonKStrasserFAnkerSD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol2011; 12: 489–495.
13.
ReidJMcKennaHFitzsimonsD, et al. The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members. Int J Nurs Stud2009; 46: 606–616.
